Hyperbaric oxygen therapy is FDA-approved for 13 medical conditions — decompression sickness, diabetic wounds, carbon monoxide poisoning. A widely-cited 2020 Israeli study showed telomere lengthening of 20–38% and senescent cell reduction of up to 37% after 60 sessions. But the study had no control group, measured only blood immune cells, and came from researchers who run a commercial HBOT longevity clinic charging $36,000–$51,000 per program. Here’s whether the science justifies the price tag.
Hyperbaric oxygen therapy involves breathing 100% oxygen at 1.5–3.0 times normal atmospheric pressure inside a sealed chamber for 60–120 minutes per session. Under these conditions, blood plasma oxygen levels increase dramatically — far beyond what hemoglobin alone can carry. This hyperoxygenation accelerates wound healing, promotes new blood vessel growth (angiogenesis), reduces inflammation, and may trigger stem cell mobilization.
The therapy works through what researchers call the “hyperoxic-hypoxic paradox”: when you alternate between high-oxygen periods (inside the chamber) and normal oxygen (outside), your body interprets the transition as a relative oxygen drop, triggering regenerative responses that normally occur during hypoxia — including growth factor production and stem cell activation.
The study that launched HBOT into longevity conversations was published in Aging in 2020 by Efrati and colleagues at Tel Aviv University / Shamir Medical Center. Thirty-five healthy adults aged 64+ received 60 daily HBOT sessions (100% oxygen at 2 ATA with three air breaks per session). Telomere length in T helper cells, T cytotoxic cells, natural killer cells, and B cells increased 20–38%, while senescent cell populations decreased up to 37%.
This is a genuinely interesting finding. However, the study has critical limitations that are often glossed over in marketing materials. There was no control group — meaning we cannot rule out that the improvements resulted from the daily routine, social interaction, or regression to the mean. The measurements were confined to peripheral blood immune cells, not the tissues and organs where aging causes the most damage. And telomere length — as we covered in our biological age testing review — is among the weakest individual aging predictors, with poor test-retest reliability.
The same research group has published studies showing cognitive improvements in older adults following HBOT protocols, including enhanced cerebral blood flow and improved memory performance. These findings are interesting but come from the same team, the same clinic, and suffer from the same design limitations.
HBOT has robust evidence for its FDA-approved medical indications. For longevity in healthy adults, the evidence consists primarily of uncontrolled studies from a single research group with commercial interests. The biomarker changes (telomeres, senescent cells) are intriguing but measured in blood cells only, without controls, and using markers with known limitations. At $6,000–$51,000, the cost-benefit calculation is unfavorable given the current evidence.
A single HBOT session costs $75–$400 depending on the chamber type and location. Longevity protocols typically require 40–60 sessions — meaning $6,000–$15,000 at standard clinics, and $36,000–$51,000 at premium clinics like Aviv that include personalized care plans. Insurance covers only the 13 FDA-approved indications. Home soft-shell chambers ($5,000–$15,000) operate at lower pressures (1.3–1.5 ATA) than clinical studies (2.0 ATA) and may not reproduce the research conditions.
For perspective: $10,000 spent on HBOT sessions could instead fund a decade of gym membership, a year of high-quality whole food nutrition, annual comprehensive blood panels, and proven supplements — all of which have far stronger longevity evidence.
HBOT is legitimate medicine for its approved indications. For longevity? The science is early, the studies lack controls, the cost is extreme, and the primary evidence comes from researchers with direct commercial interests. If you have $10,000–$50,000 for longevity, exercise, nutrition, sleep optimization, and annual biomarker testing will almost certainly produce better outcomes. Watch for randomized controlled trials with proper sham groups — those will determine whether HBOT earns a place in evidence-based longevity medicine.